Peter Carmeliet

159.7k citations

729 papers · 100.0k indexed · 36 hit papers · h-index 151

Impact in

Cancer Research top 0.01%
- Cancer, Hypoxia, and Metabolism
- Protease and Inhibitor Mechanisms
Immunology and Allergy top 0.02%
- Cell Adhesion Molecules Research

Papers in

Cancer Research 283
- Cancer, Hypoxia, and Metabolism 151
- Protease and Inhibitor Mechanisms 108
Hematology 124
- Blood Coagulation and Thrombosis Mechanisms 109

Co-authors: Rakesh K. Jain Lieve Moons Mieke Dewerchin D Collen Michael Potente Désiré Collen Holger K. Eltzschig Holger Gerhardt
Journals: Journal of Clinical Investigation (38 papers)Circulation (27 papers)Blood (26 papers)Nature (21 papers)Circulation Research (16 papers)
Partner nations: Belgium United States France

In The Last Decade

Peter Carmeliet

724 papers receiving 98.2k citations

Hit Papers

15 papers align trajectories log scale

Fatty acid oxidation organizes mitochondrial supercomplexes to sustain astrocytic ROS and cognition 2023 · 94 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2023 Nature Metabolism
2023 Nature reviews. Cancer
2023 Nature Reviews Drug Discovery
2022 Nature reviews. Immunology
2020 Nature reviews. Immunology
2020 Circulation Research
2019 Cell Metabolism
2018 Nature Medicine
2017 Physiological Reviews
2016 Nature
2016 Nature
2015 Circulation Research
2011 New England Journal of Medicine
2011 Nature Reviews Drug Discovery
2011 Nature
2011 Cell
2007 Cell
2006 Nature Biotechnology
2005 Nature
2005 Oncology
2005 Nature
2004 Proceedings of the National Academy of Sciences
2003 Nature Medicine
2002 Nature Medicine
2002 Cancer Cell
2002 Nature Reviews Molecular Cell Biology
2001 Nature Medicine
2000 Nature Medicine
2000 Nature
1999 Nature Medicine
1998 Nature
1998 Nature Medicine
1997 Nature Genetics
1996 Nature
1996 Nature
1994 Nature

Peers

Countries citing papers authored by Peter Carmeliet

Since Specialization

Citations

This map shows the geographic impact of Peter Carmeliet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Carmeliet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Carmeliet more than expected).

Fields of papers citing papers by Peter Carmeliet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Carmeliet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Carmeliet. The network helps show where Peter Carmeliet may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter Carmeliet, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Carmeliet Line = papers co-authored together Peter Carmeliet links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Alveolar epithelial cells mitigate neutrophilic inflammation in lung injury through regulating mitochondrial fatty acid oxidation Nature Communications ·Kuei‐Pin Chung, Dicky Hans Jauwerissa, G. Keele, Chia‐Lang Hsu, Marelli Pablo, Min‐Shu Hsieh, Han‐Chun Kuo, Ya‐Ting Lin, Yi‐Hsiu Juan, Kiichi Nakahira, Yen‐Fu Chen, Olga V. Belopukhova, Sheng‐Yuan Ruan, Jung‐Yien Chien, Maria Plataki, Suzanne M. Cloonan, Peter Carmeliet, Augustine M.K. Choi, Ching‐Hua Kuo, Chong‐Jen Yu	2024	18
2	Blockade of Myeloid-Derived Suppressor Cell Expansion with All- Trans Retinoic Acid Increases the Efficacy of Antiangiogenic Therapy Cancer Research ·Noris Araujo, Seiichiro Kokubun, Mark Wroblewski, Isabel Ben‐Batalla, Ines Miranda Santos, Federico Taverna, Graeme Foggo, L. Groshev, 刘卡, Stefan Vinckier, Johanna M. Brandner, Klaus Pantel, Carsten Bokemeyer, Thomas Vogl, Johannes Roth, Peter Carmeliet, Sonja Loges	2018	97
3	PP2A Inactivation Mediated by PPP2R4 Haploinsufficiency Promotes Cancer Development Cancer Research ·Ward Sents, Bob Meeusen, Rini Pahmawati Simangunsong, Enrico Radaelli, Xavier Sagaert, Letícia Eduarda Bender, Dorien Haesen, Caroline Lambrecht, Mieke Dewerchin, Peter Carmeliet, Jukka Westermarck, Anna Sablina, Veerle Janssens	2017	31
4	Tumor Hypoxia Does Not Drive Differentiation of Tumor-Associated Macrophages but Rather Fine-Tunes the M2-like Macrophage Population Cancer Research ·Damya Laoui, Eva Van Overmeire, Giusy Di Conza, Chiara Aldeni, Jiri Keirsse, Yannick Morias, Kiavash Movahedi, Isabelle Houbracken, Elio Schouppe, Yvon Elkrim, Oussama Karroum, Bénédicte F. Jordan, Peter Carmeliet, Conny Gysemans, Patrick De Baetselier, Massimiliano Mazzone, Jo A. Van Ginderachter	2013	338
5	Prolyl hydroxylase 3 (PHD3) is essential for hypoxic regulation of neutrophilic inflammation in humans and mice Journal of Clinical Investigation ·Sarah R. Walmsley, Edwin R. Chilvers, A. A. Roger Thompson, Marina Soares de Azerêdo, Helen M. Marriott, Lisa C. Parker, Gary S. Shaw, Lothar Moedel, Martin Schneider, Ian Sabroe, David H. Dockrell, Marta Milo, Cormac T. Taylor, Randall S. Johnson, Christopher W. Pugh, Peter J. Ratcliffe, Patrick H. Maxwell, Peter Carmeliet, Moira K. B. Whyte	2011	132
6	Anti–Placental Growth Factor Reduces Bone Metastasis by Blocking Tumor Cell Engraftment and Osteoclast Differentiation Cancer Research ·Lieve Coenegrachts, Christa Maes, Sophie Torrekens, Riet Van Looveren, Massimiliano Mazzone, Theresa A. Guise, Roger Bouillon, Koh Shiomi, Peter Carmeliet, Geert Carmeliet	2010	40
7	Malignant cells fuel tumor growth by educating infiltrating leukocytes to produce the mitogen Gas6 Blood ·Sonja Loges, Thomas Schmidt, Marc Tjwa, Katie Van Geyte, Dirk Lievens, Esther Lutgens, Davy Vanhoutte, Delphine Borgel, Stéphane Plaisance, Marc Hoylaerts, Aernout Luttun, Mieke Dewerchin, Bart Jonckx, Peter Carmeliet	2009	137
8	G Protein-Coupled Receptor APJ and Its Ligand Apelin Act Downstream of Cripto to Specify Embryonic Stem Cells Toward the Cardiac Lineage Through Extracellular Signal-Regulated Kinase/p70S6 Kinase Signaling Pathway Circulation Research ·Cristina D’Aniello, Enza Lonardo, Dionysius Priyanto, Ombretta Guardiola, Zhili Liu, Giovanna L. Liguori, Monica Autiero, Peter Carmeliet, Gabriella Minchiotti	2009	80
9	Growth Arrest Specific Protein 6 Participates in DOCA-Induced Target-Organ Damage Hypertension ·Joon-Keun Park, Luciana Soldera Corseuil, Torsten Kirsch, Carsten Lindschau, U. Klinge, Arnd Heuser, Ralph Plehm, Mihail Todiraş, Peter Carmeliet, Hermann Haller, Friedrich C. Luft, Dominik N. Müller, Anette Fiebeler	2009	14
10	Absence of SPARC results in increased cardiac rupture and dysfunction after acute myocardial infarction The Journal of Experimental Medicine ·Mark W.M. Schellings, Davy Vanhoutte, Melissa Swinnen, Jack P.M. Cleutjens, Jacques Debets, Rick E.W. van Leeuwen, Jan D’hooge, Frans Van de Werf, Peter Carmeliet, Yigal M. Pinto, E. Helene Sage, Stéphane Heymans	2008	166
11	Overlap Syndrome of Cardiac Sodium Channel Disease in Mice Carrying the Equivalent Mutation of Human SCN5A -1795insD Circulation ·Carol Ann Remme, Arie O. Verkerk, Dieter Nuyens, Antoni C.G. van Ginneken, Sandra van Brunschot, Charly Belterman, Ronald Wilders, Marian A. van Roon, Hanno L. Tan, Arthur A.M. Wilde, Peter Carmeliet, Jacques M.T. de Bakker, Marieke W. Veldkamp, Connie R. Bezzina	2006	139
12	Hypoxia-Inducible Factors 1α and 2α Regulate Trophoblast Differentiation Molecular and Cellular Biology ·Karen D. Cowden Dahl, Benjamin H. Fryer, Fiona Mack, Veerle Compernolle, Emin Maltepe, David M. Adelman, Peter Carmeliet, M. Celeste Simon	2005	185
13	Dendritic Cell Subsets Differentially Regulate Angiogenesis in Human Ovarian Cancer Cancer Research ·Tyler J. Curiel, Pui Cheng, Peter Mottram, Xavier Álvarez, Lieve Moons, 須田悟, Shuang Wei, Linhua Zou, Ilona Kryczek, Gary W. Hoyle, Andrew A. Lackner, Peter Carmeliet, Weiping Zou	2004	228
14	A Sertoli cell-selective knockout of the androgen receptor causes spermatogenic arrest in meiosis Proceedings of the National Academy of Sciences ·Karel De Gendt, Johannes V. Swinnen, Philippa T. K. Saunders, Luc Schoonjans, Mieke Dewerchin, Ann Devos, Karen A. L. Tan, Nina Atanassova, Frank Claessens, Charlotte Lécureuil, Walter Heyns, Peter Carmeliet, Florian Guillou, Richard M. Sharpe, Guido Verhoeven Hit paper breakdown →	2004	633
15	VEGF: a critical player in neurodegeneration Journal of Clinical Investigation ·Erik Storkebaum, Peter Carmeliet	2004	22
16	Soluble VEGF isoforms are essential for establishingepiphyseal vascularization and regulating chondrocyte development and survival Journal of Clinical Investigation ·Christa Maes, Ingrid Stockmans, Karen Moermans, Riet Van Looveren, Nico Smets, Peter Carmeliet, Roger Bouillon, Geert Carmeliet	2004	183
17	Soluble VEGF isoforms are essential for establishingepiphyseal vascularization and regulating chondrocyte development and survival Journal of Clinical Investigation ·Christa Maes, Ingrid Stockmans, Karen Moermans, Riet Van Looveren, Nico Smets, Peter Carmeliet, Roger Bouillon, Geert Carmeliet	2004	196
18	VEGF: a critical player in neurodegeneration Journal of Clinical Investigation ·Erik Storkebaum, Peter Carmeliet	2004	202
19	Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms Journal of Clinical Investigation ·Ingeborg Stalmans, Yin‐Shan Ng, Richard M. Rohan, Marcus Fruttiger, Ann Bouché, Edoardo Timitilli, Hajime Fujisawa, Bart Hermans, Moshe Shani, Sandra Jansen, Dan Hicklin, David J. Anderson, Tom A. Gardiner, Hans‐Peter Hammes, Lieve Moons, Mieke Dewerchin, Désiré Collen, Peter Carmeliet, Patrìcia A. D'Amore	2002	301
20	Ovulation in Plasminogen-Deficient Mice¹ Endocrinology ·Annelii Ny, Göran Leonardsson, Anna‐Carin Hägglund, Peter Hägglöf, Victoria A. Ploplis, Peter Carmeliet, Tor Ny	1999	43

About Peter Carmeliet

Peter Carmeliet is a scholar working on Cancer Research, Hematology, Molecular Biology, Immunology and Allergy and Immunology, having authored 729 papers that have together received 100.0k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (207 papers), Cancer, Hypoxia, and Metabolism (151 papers), Blood Coagulation and Thrombosis Mechanisms (109 papers), Protease and Inhibitor Mechanisms (108 papers), Axon Guidance and Neuronal Signaling (44 papers), Congenital heart defects research (37 papers), Cell Adhesion Molecules Research (32 papers) and Zebrafish Biomedical Research Applications (31 papers). The work is most often cited by research in Cancer Research (27.4k citations), Immunology and Allergy (5.0k citations), Molecular Biology (53.1k citations), Hematology (8.2k citations) and Genetics (6.4k citations). Peter Carmeliet has collaborated with scholars based in Belgium, United States and France. Frequent co-authors include Rakesh K. Jain, Lieve Moons, Mieke Dewerchin, D Collen, Michael Potente, Désiré Collen, Holger K. Eltzschig, Holger Gerhardt, Diether Lambrechts and Massimiliano Mazzone. Their work appears in journals such as Journal of Clinical Investigation, Circulation, Blood, Nature and Circulation Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact